Winship treats first lung cancer patient with T-cell receptor
4.8 (155) · $ 14.50 · In stock
Downregulation of death receptor 4 is tightly associated with positive response of EGFR mutant lung cancer to EGFR-targeted therapy and improved prognosis
How Science Became Hope 50th Anniversary of the National Cancer Act
Results released from FLAURA trial of osimertinib for first line EGFRm lung cancer - ecancer
Winship Magazine - Spring 2022 by EmoryWeb - Issuu
Winship Magazine - Spring 2022 by EmoryWeb - Issuu
As National Cancer Act turns 50, Winship Cancer Institute reflects on progress
Frontiers Cancer Therapy With TCR-Engineered T Cells: Current Strategies, Challenges, and Prospects
Mirage or long-awaited oasis: reinvigorating T-cell responses in pancreatic cancer. - Abstract - Europe PMC
Emory's Winship Joins AccessHope as Collaboration Partner
History of Winship Winship Cancer Institute
Spring/Summer 2020 Emory Health Digest
